Viewing Study NCT05566756


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-01 @ 2:15 PM
Study NCT ID: NCT05566756
Status: COMPLETED
Last Update Posted: 2025-08-27
First Post: 2022-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module